O	O	O	0	3	Two	Two	B-NP	CD	O	3	NMOD	O
O	O	O	4	12	distinct	distinct	I-NP	JJ	O	3	NMOD	O
O	O	O	13	21	pathways	pathway	I-NP	NNS	O	18	SUB	O
O	O	O	22	24	of	of	B-PP	IN	O	3	NMOD	O
T1	B-Protein	B-Protein	25	36	interleukin	interleukin	B-NP	NN	B-protein	8	NMOD	B-protein
T1	I-Protein	I-Protein	36	37	-	-	O	HYPH	I-protein	8	NMOD	I-protein
T1	I-Protein	I-Protein	37	38	5	5	B-NP	CD	I-protein	8	NMOD	I-protein
O	O	O	39	48	synthesis	synthesis	I-NP	NN	O	4	PMOD	O
O	O	O	49	51	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	52	60	allergen	allergen	B-NP	NN	B-cell_line	17	NMOD	B-cell_line
O	O	O	60	61	-	-	B-NP	HYPH	I-cell_line	17	NMOD	I-cell_line
O	O	O	61	69	specific	specific	I-NP	JJ	I-cell_line	17	NMOD	I-cell_line
O	O	O	70	75	human	human	I-NP	JJ	I-cell_line	17	NMOD	I-cell_line
O	O	O	76	77	T	T	I-NP	NN	I-cell_line	17	NMOD	I-cell_line
O	O	O	77	78	-	-	I-NP	HYPH	I-cell_line	17	NMOD	I-cell_line
O	O	O	78	82	cell	cell	I-NP	NN	I-cell_line	17	NMOD	I-cell_line
O	O	O	83	89	clones	clone	I-NP	NNS	I-cell_line	9	PMOD	I-cell_line
O	O	O	90	93	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	94	104	suppressed	suppress	I-VP	VBN	O	18	VC	O
O	O	O	105	107	by	by	B-PP	IN	O	19	VMOD	O
O	O	O	108	123	glucocorticoids	glucocorticoid	B-NP	NNS	O	20	PMOD	O
O	O	O	123	124	.	.	O	.	O	18	P	O

O	O	O	126	141	Glucocorticoids	Glucocorticoid	B-NP	NNS	O	5	SUB	O
O	O	O	142	143	(	(	O	(	O	4	DEP	O
O	O	O	143	145	GC	GC	B-NP	NN	O	4	DEP	O
O	O	O	145	146	)	)	O	)	O	1	NMOD	O
O	O	O	147	151	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	152	156	long	long	I-VP	RB	O	5	VMOD	O
O	O	O	157	161	been	be	I-VP	VBN	O	5	VC	O
O	O	O	162	166	used	use	I-VP	VBN	O	7	VC	O
O	O	O	167	169	as	as	B-PP	IN	O	8	VMOD	O
O	O	O	170	173	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	174	178	most	most	I-NP	RBS	O	12	AMOD	O
O	O	O	179	188	effective	effective	I-NP	JJ	O	13	NMOD	O
O	O	O	189	195	agents	agent	I-NP	NNS	O	9	PMOD	O
O	O	O	196	199	for	for	B-PP	IN	O	13	NMOD	O
O	O	O	200	203	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	204	213	treatment	treatment	I-NP	NN	O	14	PMOD	O
O	O	O	214	216	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	217	225	allergic	allergic	B-NP	JJ	O	19	NMOD	O
O	O	O	226	234	diseases	disease	I-NP	NNS	O	17	PMOD	O
O	O	O	235	246	accompanied	accompany	B-VP	VBN	O	19	NMOD	O
O	O	O	247	249	by	by	B-PP	IN	O	20	VMOD	O
O	O	O	250	262	eosinophilia	eosinophilia	B-NP	NN	O	21	PMOD	O
O	O	O	263	267	such	such	B-PP	JJ	O	24	PMOD	O
O	O	O	268	270	as	as	I-PP	IN	O	22	NMOD	O
O	O	O	271	278	chronic	chronic	B-NP	JJ	O	26	NMOD	O
O	O	O	279	285	asthma	asthma	I-NP	NN	O	29	NMOD	O
O	O	O	286	289	and	and	O	CC	O	29	NMOD	O
O	O	O	290	296	atopic	atopic	B-NP	JJ	O	29	NMOD	O
O	O	O	297	307	dermatitis	dermatitis	I-NP	NN	O	24	PMOD	O
O	O	O	307	308	.	.	O	.	O	5	P	O

O	O	O	309	312	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	313	324	development	development	I-NP	NN	O	7	SUB	O
O	O	O	325	327	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	328	335	chronic	chronic	B-NP	JJ	O	5	AMOD	O
O	O	O	336	348	eosinophilic	eosinophilic	I-NP	JJ	O	6	NMOD	O
O	O	O	349	361	inflammation	inflammation	I-NP	NN	O	3	PMOD	O
O	O	O	362	364	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	365	374	dependent	dependent	B-ADJP	JJ	O	7	PRD	O
O	O	O	375	377	on	on	B-PP	IN	O	8	AMOD	O
T2	B-Protein	B-Protein	378	389	interleukin	interleukin	B-NP	NN	B-protein	12	NMOD	B-protein
T2	I-Protein	I-Protein	389	390	-	-	O	HYPH	O	12	P	O
T2	I-Protein	I-Protein	390	391	5	5	B-NP	CD	O	24	NMOD	O
O	O	O	392	393	(	(	O	(	O	17	DEP	O
T3	B-Protein	B-Protein	393	395	IL	IL	B-NP	NN	B-protein	16	NMOD	B-protein
T3	I-Protein	I-Protein	395	396	-	-	O	HYPH	I-protein	16	P	I-protein
T3	I-Protein	I-Protein	396	397	5	5	B-NP	CD	I-protein	17	DEP	I-protein
O	O	O	397	398	)	)	O	)	O	12	NMOD	O
O	O	O	398	399	,	,	O	,	O	24	P	O
O	O	O	400	401	a	a	B-NP	DT	O	24	NMOD	O
O	O	O	402	411	selective	selective	I-NP	JJ	B-protein	24	NMOD	B-protein
O	O	O	412	422	eosinophil	eosinophil	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	O	422	423	-	-	O	HYPH	I-protein	24	NMOD	I-protein
O	O	O	423	433	activating	activate	B-VP	VBG	I-protein	24	NMOD	I-protein
O	O	O	434	440	factor	factor	B-NP	NN	I-protein	9	PMOD	I-protein
O	O	O	440	441	,	,	O	,	O	24	P	O
O	O	O	442	450	produced	produce	B-VP	VBN	O	24	NMOD	O
O	O	O	451	453	by	by	B-PP	IN	O	26	VMOD	O
O	O	O	454	460	helper	helper	B-NP	NN	B-cell_type	30	NMOD	B-cell_type
O	O	O	461	462	T	T	I-NP	NN	I-cell_type	30	NMOD	I-cell_type
O	O	O	463	468	cells	cell	I-NP	NNS	I-cell_type	27	PMOD	I-cell_type
O	O	O	468	469	.	.	O	.	O	7	P	O

O	O	O	470	472	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	473	482	delineate	delineate	I-VP	VB	O	14	VMOD	O
O	O	O	483	486	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	487	497	regulatory	regulatory	I-NP	JJ	O	5	NMOD	O
O	O	O	498	508	mechanisms	mechanism	I-NP	NNS	O	2	OBJ	O
O	O	O	509	511	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	512	517	human	human	B-NP	JJ	O	11	NMOD	O
T4	B-Protein	B-Protein	518	520	IL	IL	I-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Protein	I-Protein	520	521	-	-	O	HYPH	I-protein	11	NMOD	I-protein
T4	I-Protein	I-Protein	521	522	5	5	B-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	523	532	synthesis	synthesis	I-NP	NN	O	6	PMOD	O
O	O	O	532	533	,	,	O	,	O	14	P	O
O	O	O	534	536	we	we	B-NP	PRP	O	14	SUB	O
O	O	O	537	548	established	establish	B-VP	VBD	O	0	ROOT	O
O	O	O	549	557	allergen	allergen	B-NP	NN	O	23	NMOD	O
O	O	O	557	558	-	-	B-NP	HYPH	O	23	P	O
O	O	O	558	566	specific	specific	I-NP	JJ	O	23	NMOD	O
O	O	O	567	570	CD4	CD4	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	570	571	+	+	I-NP	SYM	O	23	NMOD	O
O	O	O	572	573	T	T	I-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	O	573	574	-	-	I-NP	HYPH	I-cell_line	23	NMOD	I-cell_line
O	O	O	574	578	cell	cell	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	O	579	585	clones	clone	I-NP	NNS	I-cell_line	14	OBJ	I-cell_line
O	O	O	586	590	from	from	B-PP	IN	O	14	VMOD	O
O	O	O	591	600	asthmatic	asthmatic	B-NP	JJ	O	26	NMOD	O
O	O	O	601	609	patients	patient	I-NP	NNS	O	24	PMOD	O
O	O	O	609	610	.	.	O	.	O	14	P	O

O	O	O	611	613	GC	GC	B-NP	NN	O	3	SUB	O
O	O	O	614	625	efficiently	efficiently	B-ADVP	RB	O	3	VMOD	O
O	O	O	626	636	suppressed	suppress	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	B-Protein	637	639	IL	IL	B-NP	NN	B-protein	7	NMOD	B-protein
T5	I-Protein	I-Protein	639	640	-	-	O	HYPH	I-protein	7	NMOD	I-protein
T5	I-Protein	I-Protein	640	641	5	5	B-NP	CD	I-protein	7	NMOD	I-protein
O	O	O	642	651	synthesis	synthesis	I-NP	NN	O	3	OBJ	O
O	O	O	652	654	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	655	656	T	T	B-NP	NN	B-cell_line	12	NMOD	B-cell_line
O	O	O	656	657	-	-	I-NP	HYPH	I-cell_line	12	NMOD	I-cell_line
O	O	O	657	661	cell	cell	I-NP	NN	I-cell_line	12	NMOD	I-cell_line
O	O	O	662	668	clones	clone	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	O	669	678	activated	activate	B-VP	VBN	O	12	NMOD	O
O	O	O	679	682	via	via	B-PP	IN	O	13	VMOD	O
O	O	O	683	689	either	either	O	CC	O	14	PMOD	O
O	O	O	690	691	T	T	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	691	692	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
O	O	O	692	696	cell	cell	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	697	705	receptor	receptor	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	706	707	(	(	O	(	O	22	DEP	O
O	O	O	707	710	TCR	TCR	B-NP	NN	B-protein	22	DEP	B-protein
O	O	O	710	711	)	)	O	)	O	19	NMOD	O
O	O	O	712	714	or	or	O	CC	O	27	NMOD	O
T13	B-Entity	B-Entity	715	717	IL	IL	B-NP	NN	B-protein	27	NMOD	B-protein
T13	I-Entity	I-Entity	717	718	-	-	O	HYPH	I-protein	24	NMOD	I-protein
T13	I-Entity	I-Entity	718	719	2	2	B-NP	CD	I-protein	27	NMOD	I-protein
T13	I-Entity	I-Entity	720	728	receptor	receptor	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	O	729	730	(	(	O	(	O	32	DEP	O
T14	B-Entity	B-Entity	730	732	IL	IL	B-NP	NN	B-protein	31	NMOD	B-protein
T14	I-Entity	I-Entity	732	733	-	-	B-NP	HYPH	I-protein	31	P	I-protein
T14	I-Entity	I-Entity	733	735	2R	2R	I-NP	NN	I-protein	32	DEP	I-protein
O	O	O	735	736	)	)	O	)	O	27	NMOD	O
O	O	O	736	737	.	.	O	.	O	3	P	O

O	O	O	738	747	Induction	Induction	B-NP	NN	O	14	SUB	O
O	O	O	748	750	of	of	B-PP	IN	O	1	NMOD	O
T6	B-Protein	B-Protein	751	753	IL	IL	B-NP	NN	B-RNA	6	NMOD	B-RNA
T6	I-Protein	I-Protein	753	754	-	-	O	HYPH	I-RNA	6	NMOD	I-RNA
T6	I-Protein	I-Protein	754	755	5	5	B-NP	CD	I-RNA	6	NMOD	I-RNA
O	O	O	756	760	mRNA	mRNA	I-NP	NN	I-RNA	2	PMOD	I-RNA
O	O	O	761	765	upon	upon	B-PP	IN	O	1	NMOD	O
O	O	O	766	769	TCR	TCR	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	770	773	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	774	776	IL	IL	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	776	777	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
O	O	O	777	779	2R	2R	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	780	791	stimulation	stimulation	I-NP	NN	O	7	PMOD	O
O	O	O	792	795	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	796	803	totally	totally	I-VP	RB	O	14	VMOD	O
O	O	O	804	813	inhibited	inhibit	I-VP	VBN	O	14	VC	O
O	O	O	814	816	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	817	830	dexamethasone	dexamethasone	B-NP	NN	O	17	PMOD	O
O	O	O	830	831	.	.	O	.	O	14	P	O

O	O	O	832	837	Human	Human	B-NP	JJ	B-DNA	11	NMOD	B-DNA
T7	B-Protein	B-Protein	838	840	IL	IL	I-NP	NN	I-DNA	11	NMOD	I-DNA
T7	I-Protein	I-Protein	840	841	-	-	I-NP	HYPH	I-DNA	11	NMOD	I-DNA
T7	I-Protein	I-Protein	841	842	5	5	I-NP	CD	I-DNA	11	NMOD	I-DNA
O	O	O	843	851	promoter	promoter	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	O	851	852	/	/	B-NP	SYM	O	11	NMOD	O
O	O	O	852	860	enhancer	enhancer	I-NP	NN	B-DNA	11	NMOD	B-DNA
O	O	O	860	861	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	O	861	871	luciferase	luciferase	I-NP	NN	B-DNA	11	NMOD	B-DNA
O	O	O	872	876	gene	gene	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	O	877	886	construct	construct	I-NP	NN	I-DNA	18	SUB	I-DNA
O	O	O	887	898	transfected	transfecte	B-VP	VBN	O	11	NMOD	O
O	O	O	899	901	to	to	B-PP	TO	O	12	VMOD	O
O	O	O	902	903	T	T	B-NP	NN	B-cell_line	17	NMOD	B-cell_line
O	O	O	903	904	-	-	I-NP	HYPH	I-cell_line	17	NMOD	I-cell_line
O	O	O	904	908	cell	cell	I-NP	NN	I-cell_line	17	NMOD	I-cell_line
O	O	O	909	915	clones	clone	I-NP	NNS	I-cell_line	13	PMOD	I-cell_line
O	O	O	916	919	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	920	931	transcribed	transcribe	I-VP	VBN	O	18	VC	O
O	O	O	932	934	on	on	B-PP	IN	O	19	VMOD	O
O	O	O	935	941	either	either	O	CC	O	27	NMOD	O
O	O	O	942	945	TCR	TCR	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	946	948	or	or	I-NP	CC	O	27	NMOD	O
O	O	O	949	951	IL	IL	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	951	952	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
O	O	O	952	954	2R	2R	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	955	966	stimulation	stimulation	I-NP	NN	O	20	PMOD	O
O	O	O	967	970	and	and	O	CC	O	18	VMOD	O
O	O	O	971	974	was	be	B-VP	VBD	O	18	VMOD	O
O	O	O	975	982	clearly	clearly	I-VP	RB	O	29	VMOD	O
O	O	O	983	996	downregulated	downregulate	I-VP	VBN	O	29	VC	O
O	O	O	997	999	by	by	B-PP	IN	O	31	VMOD	O
O	O	O	1000	1013	dexamethasone	dexamethasone	B-NP	NN	O	32	PMOD	O
O	O	O	1013	1014	,	,	O	,	O	18	P	O
O	O	O	1015	1025	indicating	indicate	B-VP	VBG	O	18	VMOD	O
O	O	O	1026	1030	that	that	B-SBAR	IN	O	35	VMOD	O
O	O	O	1031	1034	the	the	B-NP	DT	O	47	NMOD	O
O	O	O	1035	1048	approximately	approximately	I-NP	RB	O	47	NMOD	O
O	O	O	1049	1052	500	500	I-NP	CD	B-DNA	47	NMOD	B-DNA
O	O	O	1052	1053	-	-	I-NP	HYPH	I-DNA	47	NMOD	I-DNA
O	O	O	1053	1055	bp	bp	I-NP	NN	I-DNA	47	NMOD	I-DNA
O	O	O	1056	1061	human	human	I-NP	JJ	I-DNA	47	NMOD	I-DNA
T8	B-Protein	B-Protein	1062	1064	IL	IL	I-NP	NN	I-DNA	47	NMOD	I-DNA
T8	I-Protein	I-Protein	1064	1065	-	-	I-NP	HYPH	I-DNA	47	NMOD	I-DNA
T8	I-Protein	I-Protein	1065	1066	5	5	I-NP	CD	I-DNA	47	NMOD	I-DNA
T15	B-Entity	B-Entity	1067	1071	gene	gene	I-NP	NN	I-DNA	47	NMOD	I-DNA
T15	I-Entity	I-Entity	1072	1079	segment	segment	I-NP	NN	I-DNA	56	SUB	I-DNA
O	O	O	1080	1087	located	locate	B-VP	VBN	O	47	NMOD	O
T16	B-Entity	B-Entity	1088	1089	5	5	B-NP	CD	B-DNA	51	AMOD	B-DNA
T16	I-Entity	I-Entity	1089	1090	'	'	I-NP	SYM	I-DNA	51	AMOD	I-DNA
T16	I-Entity	I-Entity	1091	1099	upstream	upstream	I-NP	RB	I-DNA	48	AMOD	I-DNA
O	O	O	1100	1102	of	of	B-PP	IN	O	51	AMOD	O
O	O	O	1103	1106	the	the	B-NP	DT	O	55	NMOD	O
O	O	O	1107	1113	coding	cod	I-NP	VBG	O	55	NMOD	O
O	O	O	1114	1120	region	region	I-NP	NN	O	52	PMOD	O
O	O	O	1121	1129	contains	contain	B-VP	VBZ	O	36	SBAR	O
T17	B-Entity	B-Entity	1130	1140	activation	activation	B-NP	NN	O	61	NMOD	O
T17	I-Entity	I-Entity	1140	1141	-	-	I-NP	HYPH	O	61	P	O
T17	I-Entity	I-Entity	1141	1150	inducible	inducible	I-NP	JJ	B-DNA	61	NMOD	B-DNA
T17,T18	I-Entity,B-Entity	I-Entity,B-Entity	1151	1159	enhancer	enhancer	I-NP	NN	I-DNA	61	NMOD	I-DNA
T17,T18	I-Entity,I-Entity	I-Entity,I-Entity	1160	1168	elements	element	I-NP	NNS	I-DNA	56	OBJ	I-DNA
O	O	O	1169	1180	responsible	responsible	B-ADJP	JJ	O	61	NMOD	O
O	O	O	1181	1184	for	for	B-PP	IN	O	62	AMOD	O
O	O	O	1185	1188	the	the	B-NP	DT	O	65	NMOD	O
O	O	O	1189	1199	regulation	regulation	I-NP	NN	O	63	PMOD	O
O	O	O	1200	1202	by	by	B-PP	IN	O	65	NMOD	O
O	O	O	1203	1205	GC	GC	B-NP	NN	O	66	PMOD	O
O	O	O	1205	1206	.	.	O	.	O	18	P	O

O	O	O	1207	1222	Electrophoretic	Electrophoretic	B-NP	JJ	O	5	NMOD	O
O	O	O	1223	1231	mobility	mobility	I-NP	NN	O	5	NMOD	O
O	O	O	1232	1237	shift	shift	I-NP	NN	O	5	NMOD	O
O	O	O	1238	1243	assay	assay	I-NP	NN	O	5	NMOD	O
O	O	O	1244	1252	analysis	analysis	I-NP	NN	O	6	SUB	O
O	O	O	1253	1262	suggested	suggest	B-VP	VBD	O	0	ROOT	O
O	O	O	1263	1267	that	that	B-SBAR	IN	O	6	VMOD	O
T19	B-Entity	B-Entity	1268	1270	AP	AP	B-NP	NN	B-protein	14	NMOD	B-protein
T19	I-Entity	I-Entity	1270	1271	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T19	I-Entity	I-Entity	1271	1272	1	1	I-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	1273	1276	and	and	I-NP	CC	O	14	NMOD	O
T20	B-Entity	B-Entity	1277	1279	NF	NF	I-NP	NN	B-protein	14	NMOD	B-protein
T20	I-Entity	I-Entity	1279	1280	-	-	O	HYPH	I-protein	14	NMOD	I-protein
T20	I-Entity	I-Entity	1280	1286	kappaB	kappaB	B-NP	NN	I-protein	15	SUB	I-protein
O	O	O	1287	1290	are	be	B-VP	VBP	O	7	SBAR	O
O	O	O	1291	1296	among	among	B-PP	IN	O	15	PRD	O
O	O	O	1297	1300	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1301	1309	possible	possible	I-NP	JJ	O	19	NMOD	O
O	O	O	1310	1317	targets	target	I-NP	NNS	O	16	PMOD	O
O	O	O	1318	1320	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1321	1323	GC	GC	B-NP	NN	O	22	NMOD	O
O	O	O	1324	1331	actions	action	I-NP	NNS	O	20	PMOD	O
O	O	O	1332	1334	on	on	B-PP	IN	O	22	NMOD	O
O	O	O	1335	1338	TCR	TCR	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	1338	1339	-	-	B-NP	HYPH	O	28	P	O
O	O	O	1339	1349	stimulated	stimulate	I-NP	VBN	B-cell_type	28	NMOD	B-cell_type
O	O	O	1350	1351	T	T	I-NP	NN	I-cell_type	28	NMOD	I-cell_type
O	O	O	1352	1357	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	O	1357	1358	.	.	O	.	O	6	P	O

O	O	O	1359	1361	NF	NF	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	1361	1362	-	-	I-NP	HYPH	I-protein	3	NMOD	I-protein
O	O	O	1362	1364	AT	AT	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	1365	1368	and	and	I-NP	CC	O	7	NMOD	O
T21	B-Entity	B-Entity	1369	1371	NF	NF	I-NP	NN	B-protein	7	NMOD	B-protein
T21	I-Entity	I-Entity	1371	1372	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T21	I-Entity	I-Entity	1372	1378	kappaB	kappaB	I-NP	NN	I-protein	8	SUB	I-protein
O	O	O	1379	1383	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1384	1387	not	not	I-VP	RB	O	8	VMOD	O
O	O	O	1388	1401	significantly	significantly	I-VP	RB	O	8	VMOD	O
O	O	O	1402	1409	induced	induce	I-VP	VBN	O	8	VC	O
O	O	O	1410	1412	by	by	B-PP	IN	O	11	VMOD	O
T9	B-Protein	B-Protein	1413	1415	IL	IL	B-NP	NN	B-protein	16	NMOD	B-protein
T9	I-Protein	I-Protein	1415	1416	-	-	O	HYPH	I-protein	13	NMOD	I-protein
T9	I-Protein	I-Protein	1416	1417	2	2	B-NP	CD	I-protein	16	NMOD	I-protein
O	O	O	1418	1429	stimulation	stimulation	I-NP	NN	O	12	PMOD	O
O	O	O	1429	1430	.	.	O	.	O	8	P	O

O	O	O	1431	1434	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1435	1442	results	result	I-NP	NNS	O	30	SUB	O
O	O	O	1443	1450	showing	show	B-VP	VBG	O	2	NMOD	O
O	O	O	1451	1455	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1456	1458	GC	GC	B-NP	NN	O	6	SUB	O
O	O	O	1459	1469	suppressed	suppress	B-VP	VBD	O	4	SBAR	O
T10	B-Protein	B-Protein	1470	1472	IL	IL	B-NP	NN	B-protein	10	NMOD	B-protein
T10	I-Protein	I-Protein	1472	1473	-	-	O	HYPH	I-protein	10	NMOD	I-protein
T10	I-Protein	I-Protein	1473	1474	5	5	B-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	1475	1485	production	production	I-NP	NN	O	6	OBJ	O
O	O	O	1486	1488	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	1489	1494	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
T11	B-Protein	B-Protein	1495	1498	CD4	CD4	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	O	1498	1499	+	+	I-NP	SYM	I-cell_type	16	NMOD	I-cell_type
O	O	O	1500	1501	T	T	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	O	1502	1507	cells	cell	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	O	1508	1517	activated	activate	B-VP	VBN	O	16	NMOD	O
O	O	O	1518	1520	by	by	B-PP	IN	O	17	VMOD	O
O	O	O	1521	1524	two	two	B-NP	CD	O	21	NMOD	O
O	O	O	1525	1533	distinct	distinct	I-NP	JJ	O	21	NMOD	O
O	O	O	1534	1541	stimuli	stimulus	I-NP	NNS	O	28	NMOD	O
O	O	O	1541	1542	,	,	O	,	O	28	P	O
O	O	O	1543	1546	TCR	TCR	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	1547	1550	and	and	I-NP	CC	O	28	NMOD	O
O	O	O	1551	1553	IL	IL	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	1553	1554	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
O	O	O	1554	1556	2R	2R	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	O	1557	1568	stimulation	stimulation	I-NP	NN	O	18	PMOD	O
O	O	O	1568	1569	,	,	O	,	O	2	P	O
O	O	O	1570	1580	underscore	underscore	B-VP	VBP	O	0	ROOT	O
O	O	O	1581	1584	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	1585	1593	efficacy	efficacy	I-NP	NN	O	30	OBJ	O
O	O	O	1594	1596	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	1597	1599	GC	GC	B-NP	NN	O	33	PMOD	O
O	O	O	1600	1602	in	in	B-PP	IN	O	32	NMOD	O
O	O	O	1603	1606	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	1607	1616	treatment	treatment	I-NP	NN	O	35	PMOD	O
O	O	O	1617	1619	of	of	B-PP	IN	O	37	NMOD	O
O	O	O	1620	1628	allergic	allergic	B-NP	JJ	O	40	NMOD	O
O	O	O	1629	1637	diseases	disease	I-NP	NNS	O	38	PMOD	O
O	O	O	1638	1641	via	via	B-PP	IN	O	37	NMOD	O
O	O	O	1642	1653	suppression	suppression	B-NP	NN	O	41	PMOD	O
O	O	O	1654	1656	of	of	B-PP	IN	O	42	NMOD	O
O	O	O	1657	1658	T	T	B-NP	NN	O	50	NMOD	O
O	O	O	1658	1659	-	-	I-NP	HYPH	O	50	NMOD	O
O	O	O	1659	1663	cell	cell	I-NP	NN	O	50	NMOD	O
T12	B-Protein	B-Protein	1664	1666	IL	IL	I-NP	NN	B-protein	50	NMOD	B-protein
T12	I-Protein	I-Protein	1666	1667	-	-	O	HYPH	I-protein	50	NMOD	I-protein
T12	I-Protein	I-Protein	1667	1668	5	5	B-NP	CD	I-protein	50	NMOD	I-protein
O	O	O	1669	1678	synthesis	synthesis	I-NP	NN	O	43	PMOD	O
O	O	O	1678	1679	.	.	O	.	O	30	P	O
